Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00777712 · ClinicalTrials.gov registry record

Mechanisms Underlying Impaired Diabetic Wound Healing

A clinical trial of Diabetes and Non-healing Wounds, sponsored by University of Pittsburgh.

Recruiting
Registry status
250
Enrollment target
5
Study locations

NCT00777712 is a study of Diabetes and Non-healing Wounds that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 250 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00777712, a study of Diabetes and Non-healing Wounds, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
250 participants
Enrollment target
5
Study locations

Study Summary

The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.

Interventions

  • OTHER Blood draw

Study Locations (5)

Pennsylvania

  • University of Pittsburgh - McKeesport - Pittsburgh
  • University of Pittsburgh - Mercy - Pittsburgh
  • University of Pittsburgh - Passavant - Pittsburgh

Indiana

  • Comprehensive Wound Care Centers - Indianapolis

Ohio

  • Comprehensive Wound Care Centers - Columbus

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2008-09-01
Est. Completion 2030-12-31

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00777712

The ClinicalTrials.gov registry entry for NCT00777712 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.

NCT00777712 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Indiana, Ohio.

Frequently Asked Questions

What is clinical trial NCT00777712 about?

NCT00777712 is a clinical study titled "Mechanisms Underlying Impaired Diabetic Wound Healing". The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus w...

What is the current status of trial NCT00777712?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2008-09-01. Estimated completion is 2030-12-31.

What conditions does trial NCT00777712 study?

This clinical trial studies the following conditions: Diabetes, Non-healing Wounds.

What interventions are being tested in trial NCT00777712?

The interventions under investigation include: Blood draw (OTHER).

Who is sponsoring clinical trial NCT00777712?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00777712 being conducted?

This trial has 5 study locations across Indiana, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.